MAIA Biotechnology, Inc. (MAIA) Raises $695K in Private Placement to Advance Cancer Trial
MAIA Biotechnology, Inc. (NYSE:MAIA), a clinical-stage biopharmaceutical company, has announced a private placement agreement to raise approximately $695,000.
Maia Biotechnology Inc. (MAIA)
Market is closed
Sector: Pharmaceutical Preparations
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Citadel Investment Group Ken Griffin | 0 | $0 | 0% | |
| 2. | Renaissance Technologies Jim Simons | 0 | $0 | 0% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $1.50 | 33,333 | $49,999.50 | 1,305,059 | 2025-06-03 | Filing | |
| $1.50 | 20,000 | $30,000.00 | 588,218 | 2025-05-08 | Filing | |
| $1.50 | 66,666 | $99,999.00 | 1,271,726 | 2025-05-08 | Filing | |
| $1.50 | 33,333 | $49,999.50 | 568,218 | 2025-03-03 | Filing | |
| $1.50 | 25,000 | $37,500.00 | 1,205,060 | 2025-03-03 | Filing |
Institutional Investors' Holdings
Filing Period: Filing is Ongoing
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 14,800 | $27,380 | 0% | |
| 2. | 0 | $0 | 0% |
News See All
Billionaire Hedge Funds
